Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era-Reference-Cited by-同舟云学术

Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era

Published:2011-11-29 Issue:2 Volume:103 Page:245-251
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:

Author:

Tomita Naoto,Yokoyama Masahiro,Yamamoto Wataru,Watanabe Reina,Shimazu Yutaka,Masaki Yasufumi,Tsunoda Saburo,Hashimoto Chizuko,Murayama Kayoko,Yano Takahiro,Okamoto Rumiko,Kikuchi Ako,Tamura Kazuo,Sato Kazuya,Sunami Kazutaka,Shibayama Hirohiko,Takimoto Rishu,Ohshima Rika,Hatta Yoshihiro,Moriuchi Yukiyoshi,Kinoshita Tomohiro,Yamamoto Masahide,Numata Ayumi,Ishigatsubo Yoshiaki,Takeuchi Kengo

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2011.02139.x/fullpdf

Reference30 articles.

1. Central nervous system metastases from non-Hodgkin’s lymphoma: treatment and prophylaxis;Recht;Am J Med,1988

2. Central nervous system involvement in patients with diffuse aggressive non-Hodgkin’s lymphoma;Bashir;Am J Clin Oncol,1991

3. Isolated central nervous system relapse in aggressive non-Hodgkin’s lymphoma: the Bologna experience;Zinzani;Leuk Lymphoma,1999

4. Predictive factors for central nervous system involvement in non-Hodgkin’s lymphoma: significance of very high serum LDH concentrations;Tomita;Leuk Lymphoma,2000

5. Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin’s lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. Groupe d’Etudes des Lymphomes de l’Adulte;Haioun;Ann Oncol,2000

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secondary central nervous system involvement in patients with diffuse large B-cell lymphoma treated with rituximab combined CHOP therapy – a supplementary analysis of JCOG0601;Annals of Hematology;2024-01-27

2. Comparison of standardized prophylactic high-dose and intrathecal methotrexate for DLBCL with a high risk of CNS relapse;International Journal of Hematology;2024-01-17

3. High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma;Journal of Clinical Oncology;2023-12-10

4. Central nervous system lymphomas—Assessment and treatment and prevention of central nervous system relapse;Hematological Oncology;2023-06-29

5. Application of the Central Nervous System International Prognostic Index (CNS-IPI) score in daily practice: a retrospective analysis apart from the clinical trial at two centers in Brazil;Hematology, Transfusion and Cell Therapy;2023-03